American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -563 | -346 | -325 | -681 | -440 |
| Depreciation Amortization | 97 | 78 | 57 | 189 | 143 |
| Accounts receivable | 5 | 20 | -26 | 84 | -38 |
| Accounts payable and accrued liabilities | -48 | -25 | 43 | 293 | 247 |
| Other Working Capital | -2 | -15 | 651 | 433 | 222 |
| Other Operating Activity | 212 | 130 | 31 | -260 | -139 |
| Operating Cash Flow | $-299 | $-158 | $431 | $58 | $-5 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-4 | $N/A | $0 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,449 | 2,352 | 1,155 | 3,835 | 2,876 |
| Debt Issued | 332 | 332 | 0 | 86 | 62 |
| Debt Repayment | -7 | -6 | -3 | -88 | -85 |
| Other Financing Activity | -3,414 | -2,299 | -1,006 | -4,000 | -2,946 |
| Financing Cash Flow | $360 | $379 | $146 | $-167 | $-93 |
| Beginning Cash Position | 4 | 4 | 4 | 113 | 113 |
| End Cash Position | 61 | 225 | 581 | 4 | 15 |
| Net Cash Flow | $57 | $221 | $577 | $-109 | $-98 |
| Free Cash Flow | |||||
| Operating Cash Flow | -299 | -158 | 431 | 58 | -5 |
| Capital Expenditure | -4 | N/A | N/A | N/A | 0 |
| Free Cash Flow | -303 | -158 | 431 | 58 | -5 |